Smartphone app to support women with cancer-risk genes
Part of Cancer, Genetic & congenital clinical trials.
This study tests a smartphone app designed to help women with certain genetic mutations (like BRCA or Lynch syndrome) keep up with their cancer screening and care. It aims to make it easier to manage follow-up appointments and prevention steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and at least 18 years old.
- You have a cancer-risk genetic mutation, such as BRCA1/BRCA2 (linked to breast/ovarian cancer) or a Lynch syndrome gene (linked to colon and other cancers).
- If you have a BRCA1 mutation, you must be at least 35; for BRCA2, at least 40. For Lynch syndrome genes, minimum ages range from 20 to 30, depending on the gene.
- You can speak and read either English or Spanish.
- You have a smartphone (iPhone or Android) and can use apps.
- For Part 2, you must not have had surgery to remove both ovaries and fallopian tubes, and you must not be receiving chemotherapy now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether helping people with hereditary cancer genetic changes (like BRCA or Lynch syndrome) communicate with their at-risk relatives leads to more family members getting tested. It aims to improve cancer prevention and early detection.
This study tests a program called ApricityCare that uses your smartphone to help catch and manage side effects early. It is for people with cancer who are starting or continuing treatment that goes through the bloodstream.
This study uses a smartphone app and biological markers to predict cancer risk. It is testing whether digital and molecular data can help identify cancer earlier, especially in women with a history of certain cancers.
This study tests a new smartphone app designed to help women with breast cancer manage their chemotherapy treatment and its side effects. It aims to see if the app is easy to use and helpful for women going through chemo for the first time.
This study tests a mobile app to help people with breast cancer or a BRCA mutation who are having breast surgery with reconstruction. The app gives you information and support before and after surgery.
This study tests a smartphone application designed to help you monitor and manage side effects and symptoms while you're receiving chemotherapy or other systemic treatment for breast cancer, colorectal cancer, or lymphoma. The app may help your doctors catch problems early and support you throughout your treatment.
Hear when a new ACT-GEN trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.